Research Antibodies Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2031

According to the latest research by Future Market Insights, the research antibodies market will experience substantial growth during the forecast period 2021-2031. Demand for research antibodies will elevate in the course of the forecast period while experiencing steady growth. Increased demand for research antibodies in diagnostic purpose and determination of serious medical conditions represents lucrative growth for the research antibodies market. 

What is Driving Demand for Research Antibodies?

Research specific antibodies are something where protein is used externally to detect the unwanted molecule into the body. It is basically used to understand what is going wrong in a cell or body. It acts as a biomarker to detect life-threatening diseases.

Increasing prevalence of chronic diseases and outbreak of infectious disease is expected to drive the growth of research antibodies market across the globe. According to World Health Organization, in 2020, approximately 1.5. Mn individuals were severely affected by an infectious disease like the coronavirus who require medical attention. Moreover, an increasing number of chronic disease patient like cancer, immunological disorders, etc. will also lead to a rise in demand for the research antibodies market.

In addition, tremendous research in the field of chronic disease and its diagnosis mitigation and treatment. This will also lead to significant growth in the research antibodies market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13189

Increasing Prevalence of Chronic Disease may Grow Research Antibodies Market 

Increasing prevalence of the chronic disease is expected to reflect positive growth for the Research Antibodies market. One such disease is cancer which results in severe life threatening condition. The increasing prevalence of cancer mainly is expected to increase the demand for Research Antibodies. According to National Cancer Institute, in 2018 an estimated 16,353,421 people living with cancer of any site in the U.S.

U.S. and Canada Research Antibodies Market Outlook

U.S. and Canada are among the largest market for research antibodies market making North America dominant. The U.S is growing due to high investments for the development of structure-based drug designs model, growing research in the fields of primary and secondary antibodies, and the focus of stakeholders on research projects involving proteins associated antibodies, research on biomolecules, and genes are the key driving factors of the market in U.S and Canada.

Europe Demand Outlook for Research Antibodies

Increasing usage of research antibodies for diagnostic and also in research work and clinical trials is expected to drive the growth of the research antibodies market in these regions. Additionally, the increasing research and development funding and increasing focus of the European governments on the healthcare system also represents steady growth for the research antibodies market.

Moreover, favourable reimbursement policies in many European countries will also boost further growth of the research antibodies market.

Who are the Key Manufacturers and Suppliers of Research Antibodies?

Some of the leading manufacturers operating in the research antibodies market include

  • Thermo Fisher Scientific
  • Merck Group
  • Abcam plc
  • Becton
  • Dickinson and Company
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Agilent Technologies
  • PerkinElmer
  • Lonza
  • GenScript
  • BioLegend
  • Yashraj biotechnology Ltd.

Many leading manufacturers in the research antibodies market are focusing on getting FDA approvals for their products. For instance, In 2020, Thermo Fisher Scientific collaborated with Wuxi and Mayo Clinic To secure FDA authorization for testing COVID-19 with ELISA for detecting both IgM and IgG antibodies. In 2020, Merck partnered with Elypta to provide contract manufacturing services for Elypta’s clinical diagnostic liquid biopsy kits.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13189

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2016 – 2020
  • Market Size & Forecast 2021 to 2031
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Regional analysis includes:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Key Segments of Research Antibodies Market 

By Product Type:

  • Primary Antibodies
    • Cancer research
    • Stem cell research
    • Neurobiology research
    • Epigenetics research
    • Infectious disease research
    • Apoptosis research
  • Secondary Antibodies
    • Western Blotting
    • Flow Cytometry
    • ELISA
    • Immunohistochemistry
    • Immunofluorescence
    • Immunoprecipitation
    • Others
  • Immune Checkpoint Antibodies

By Antibodies Form:

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Others

By Source:

  • Mice
  • Rabbit
  • Others

By Application:

  • Drug Discovery & Development
  • Basic Research
  • Toxicity Screening
  • Biopharmaceutical Production
  • Drug Screening
  • Tissue Engineering
  • Forensic Testing

By End Users:

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Forensic Science Laboratories
  • Diagnostic Centers
  • Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13189

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Pelvic Floor Stimulators Market is predicted to expand at a CAGR of over 8.8% during the forecast period (2021–2031)

Increasing demand for electrical stimulation to treat urinary incontinence is expected to boost the global pelvic floor stimulator market. According to a report by Future Market Insights (FMI), the global pelvic floor stimulator market was valued at US$ 110.4 Mn in 2020 and is predicted to expand at a CAGR of over 8.8% during the forecast period (2021–2031).

Weakening of pelvic floor muscles, urinary tract infections, menopause, constipation, obesity, and alcoholism are the main causes of urinary incontinence. The rising prevalence of these conditions, added to the growing elderly population, are major drivers for the global pelvic floor stimulators market.

Similarly, a high level of portability and lower costs of mobile devices in contrast to fixed devices or surgical treatments, and progressive therapeutic results and easy access to patients through over-the-counter (OTC) medical channels are expected to drive demand.

Initiatives undertaken by government and non-governmental organizations to create awareness are increasing the demand for pelvic floor stimulators. For instance, the Australian government has started a program “National Continence Management Program.”

The government of Australia also started “The continence aids payment scheme (CAPS).” COVID-19 kicked the pelvic floor stimulators demand into high gear—and this extended to consumers increasing their adoption using online sales channels. However, lack of labor, halt on transportation, and disruptions in the supply chain, has affected device availability and growth prospects for the near future.

Manufacturers are focusing on research and development activities to develop unique and technologically advanced devices with rechargeable functionality. In March 2019 InControl Medical received FDA approval for a new Attain designed for at-home use to women in the U.S. suffering from stress, urge, mixed urinary incontinence or bowel incontinence.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13187

pelvic floor stimulators price benchmark key regions by product type, 2021

Key Takeaways from Pelvic Floor Stimulator Market Study

  • Electrical stimulators will reflect a revenue share of more than 66% with a CAGR of 9.1% owing to the high demand for treatment research for urinary incontinence.
  • Urinary Incontinence holds a share of over 75% in 2021, due to the growing geriatric population which is prone to urinary incontinence.
  • The U.K and Germany are leading markets in Europe, cumulatively accounting for over 45% of the regional value share, owing to consumer reliance on technology for health information.
  • Driven by a matured healthcare and research sector, the U.S., will account for more than 78% of the North America market by 2031.
  • China is a high potential market reflecting a 9.9% CAGR, driven by a rapidly growing consumer demographic of geriatrics.

“Increasing prevalence of pelvic floor disorders and subsequently rising increasing awareness about the benefits electrical stimulation in the treatment of urinary incontinence are driving the adoption pelvic floor stimulators on a global scale through 2031,” says the FMI Analyst.

Key Participant Insights

Key players in the market are focusing on strategic collaborations, acquisitions, and expansion. Furthermore, product launches, agreements and research sponsorships are key strategies adopted by manufacturers to expand their research and development capabilities, while increasing their sales by strengthening product portfolios in the pelvic floor stimulator market.

In August 2020, Medtronic expanded leadership to launch InterStim Micro Neurostimulator and InterStim SureScan MRI Leads, for treating bladder and bowel control conditions.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13187

Pelvic Floor Stimulators Market by Category

Product Type:

  • Electrical stimulators
  • Magnetic Stimulators

Application:

  • Urinary Incontinence
  • Sexual Dysfunction
  • Neurodegenerative Diseases

End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized clinics
  • Homecare setting

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13187

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Oscillating Positive Expiratory Pressure (OPEP) Devices Market is anticipated to grow at a CAGR of ~5% during the forecast period of 2021-2029

A new market research report by Future Market Insights (FMI) on the oscillating positive expiratory pressure (OPEP) devices market includes global industry analysis 2014–2018 and opportunity assessment  2019–2029.. According to report findings, the global oscillating positive expiratory pressure devices market was valued ~US$ 100.0 Mn in 2018, and is expected to increase at a CAGR of ~5% during the forecast period of 2019 and 2029.

Furthermore, prevalence of chronic obstructive pulmonary diseases (COPD) is on the rise due to increasing smoking population in China and aging population in Japan with respiratory disorders. Although, low awareness about oscillating positive expiratory pressure devices among healthcare professionals and patients is hampering the potential growth of the oscillating positive expiratory pressure devices market.

The study opines that the global OPEP devices market is projected to witness significant growth over the forecast period due to multiple driving factors such as increasing regional availability of the oscillating positive expiratory pressure devices. The promising growth prospects are attributed to the innovative approach followed by manufacturers in designing devices, and the increasing adoption of OPEP devices among patients with respiratory diseases.

To remain ‘ahead’ of your competitors, request for a sample 

Mouthpiece OPEP Devices – Preferred Choice for Airway Clearance

Based on the analysis of OPEP devices market by product, mouthpiece oscillating positive expiratory pressure devices are expected to hold a prominent value share in the global market. This, according to FMI’s analysis, has majorly resulted from the ease of use of these devices as well as comparatively wider availability in the market.

On the other side, based on indication, the COPD is likely to consume a majority share of the oscillating positive expiratory pressure devices market value. This is majorly due to the higher prevalence of the disease and adoption of oscillating positive expiratory pressure devices for disease management. Although, cystic fibrosis is rare disease and has limited patient pool yet adoption of oscillating positive expiratory pressure devices remains highest in cystic fibrosis patients.

oscillating positive expiratory pressure market snapshot

OPEP Devices Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global oscillating positive expiratory pressure devices market. Some of the prominent key players in the global OPEP devices market are

  • Smiths Medical Inc.,
  • Allergan plc,
  • PARI GmbH,
  • Monaghan Medical Corporation,
  • Trudell Medical International,
  • Actegy Health Ltd.,
  • WyMedical Pty Ltd,
  • R. Cegla GmbH & Co.
  • KG, etc.

The global oscillating positive expiratory pressure devices market is significantly consolidated, with top two players holding prominent shares in the market revenues. These players are offering oscillating positive expiratory pressure devices under their popular brands such as Portex®, Flutter®, and Aerobika®, among others.

Get a Customized Scope to Match Your Need Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-3397

Key Segment

Product Type

  • Facemask OPEP Devices
  • Mouthpiece OPEP Devices
  • Bottle OPEP Devices

Indication

  • COPD
  • Asthma
  • Atelectasis
  • Bronchitis
  • Bronchiectasis
  • Cystic Fibrosis
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies/ Online Sales

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-3397

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Digital Wound Measurement Devices Market A CAGR of 4.5% is projected for the forecast period ranging from 2021-2030

Wound care measurement has been acquiring immense significance in recent years. Growing incidences of traumatic injuries due to accidents and prevalence of chronic diseases such as diabetes mellitus are primary growth stimulants. Healthcare industries worldwide are adopting technologically enhanced wound management systems to provide quality care solutions to patients. As a result, digital wound measurement devices market is gaining steady ground.

Biosensors are being extensively incorporated as they are highly effective in providing critical data regarding bacterial colonization, oxygen, glucose and pH levels at the wound site, enabling doctors to diagnose and treat wounds accordingly. Several universities and institutions are augmenting their research capabilities to conduct further studies on biosensor-enabled devices.

COVID-19 Impact Analysis

The wound care market has been impacted by the coronavirus pandemic, and is anticipated to experience a moderate slowdown in growth through 2021, attributed to a decline in surgical procedures. However, the chronic wound patient pool will continue requiring treatment, ushering in a consistent revenue stream for chronic wound devices.

Practitioners are exploring opportunities to incorporate digital wound measurement devices to treat COVID-19 patients, primarily to provide relief from lung inflammation by checking and curtailing the secretion of interleukin-6, a pro-inflammatory cytokine.

Demand for homecare wound measurement devices has spiked, attributed to increase in home visit frequencies across countries for patients suffering from chronic conditions. All these factors are expected to have a considerable influence on the market’s growth trajectory in the short-term forecast period.

To remain ‘ahead’ of your competitors, request for a sample

Digital Wound Measurement Devices Market- Key Takeaways

  • A CAGR of 4.5% is projected for the forecast period ranging from 2020-2030
  • Rising smartphone and IoT device ownership is deepening telehealth penetration, providing traction to the market
  • Diabetic ulcers to account for the lion’s share owing to increasing prevalence of diabetes mellitus
  • North America to lay suzerainty over the global market, capturing over 40% market share
  • New product launches and collaborations constitute primary market expansion strategies of prominent vendors

digital wound measurement devices market

Digital Wound Measurement Devices Market- Competitive Landscape

Prominent players within the digital wound measurement devices landscape include Perceptive Solutions Inc.,

  • ARANZ Medical,
  • Smith & Nephew plc,
  • WoundVision Inc.,
  • WoundMatrix Inc.,
  • KCI,
  • Parable Health,
  • itachi Healthcare Americas,
  • 3M Company and WoundRight Technologies.

Get a Customized Scope to Match Your Need Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-717

In 2017, WoundMatrix Inc., inked a decade long partnership with the Kent Community Health NHS Foundation Trust (KCHFT) to provide telemedicine and wound care programs aimed at improving healthcare services across the United Kingdom, including wound care and management.

In 2019, 3M successfully acquired Acelity Inc. with the objective of expanding its presence in the advanced and surgical wound care segment.

In June 2020, Perceptive Solutions, Inc. unveiled its new WoundZoom Wound Centric EMR System and 3D wound-imaging software solution. This software is an integrated wound management solution, comprising a wound-centric EMR system, 3D-imaging hardware and remote patient monitoring.

In July 2020, ARANZ Medical released the Silhouette version 4.9 which includes an improved range of data analysis features, such as a percentage area reduction figure, enabling clinicians to determine the effectiveness of wound healing.

More Insights on the Digital Wound Management Devices Market

A recent market study published by FMI on the digital wound measurement devices market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. The report is segmented on the basis of wound type (diabetic ulcers, chronic wounds, burns, incisional and traumatic), end-user (hospitals & clinics) and region (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Key Segments

Wound Type

  • Diabetic Ulcer
  • Chronic Wounds
  • Burns
  • Incisional
  • Traumatic

End User

  • Hospitals
  • Clinics

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-717

Region

  • North America (U.S & Canada)
  • Latin America (Brazil, Mexico, Argentina & Rest of Latin America)
  • Europe (Germany, Italy, France, U.K., Spain, BENELUX, Russia & Rest of Europe)
  • Middle East & Africa (GCC, Turkey, Northern Africa, Southern Africa & Rest of MEA)
  • East Asia (China, Japan & South Korea)
  • South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)
  • Oceania (Australia & New Zealand)

Cell Culture Media Bags Market 2021 Revenues To Grow At 10.7% CAGR To Reach US$ 2.6 Billion By The End Of 2030

In its new market study, Future Market Insights (FMI) estimates global cell culture media bags market will register impressive growth between 2020 and 2030, progressing at a stellar CAGR of 10.7%. Furthermore, the study projects that the market will surge past a global valuation of US$ 2.6 Bn by 2030.

Cell culture refers to a process that allows cells procured from living organisms and tissues to grow outside their natural environment. Considered a remarkable advancement in the field of life sciences, the cell culture is a crucial process aiding in storing and reproducing cells obtained from animals, humans, and plants, which are then used in studies and research purposes.

The report attributes the growth of the market to soaring demand for disposable packaging solutions in life sciences R&D activities and manufacturing of biopharmaceuticals.

Moreover, the emergence of innovative techniques such as four-layered films, which provide exceptional oxygen and moisture barrier properties, is also expected to boost demand.

Having analyzed the impact of the COVID-19 pandemic, the report opines that increasing health concerns and high emphasis on biopharmaceutical research will augur well for market growth during the assessment period.

To remain ‘ahead’ of your competitors, request for a sample

Key Companies Profiled

  • Parker Hannifin Corp,
  • Pall Corporation,
  • Sartorious AG,
  • Thermo Fisher Scientific Inc.,
  • GE Healthcare Inc. and among others.

Enquiry before Buying

  • Is this research conducted by Future Market Insights?Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst.
  • What research methodology is followed by FMI?FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions.

cell culture media bags market

Key Takeaways

  • 2D bag designs are expected to account for over half of the market value, owing to their high flexibility
  • Very large bags (>3000 ml) will remain the most sought out size, owing to low contamination properties
  • By host cell, the bacterial cell segment is projected to account for the majority of market value, ascribed to an increasing number of studies on diseases caused by bacteria.
  • Biopharmaceutical manufacturing will remain a key end-use segment, capturing over 2/3rds of market value through the forecast period.
  • US will remain the largest market for cell culture media bags globally.

Get a Customized Scope to Match Your Need Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-12670

COVID-19 Impact

The outbreak of COVID-19 is expected to positively influence the demand for cell culture media bags as players operating in the healthcare and pharmaceutical sectors emphasize on high quality and safe packaging and storing solutions. Moreover, an upsurge in the number of studies and researches during the pandemic to develop a vaccine is, in turn, propelling demand for cell culture media bags.

Likewise, the need for disposable and single-use solutions for applications such as large-scale purification, cell storage, protein purification, and polishing applications in the biopharmaceutical market will continue to offer remunerative opportunities to market players through the pandemic period.

To Know More About Cell Culture Media Bags Market

A new market research report published by Future Market Insights (FMI) on the global cell culture media bags market offers a blueprint of the market. It offers insights into demand trends and provides analysis of opportunities over the forecast period, 2020-2030. The report examines the market through four different segments – bag size, bag design, application, hostel cell, end-use, and region. The report also provides extensive assessment of pricing by different key market dynamics, life cycle analysis, and technologies that are being deployed in the supply and product adoption across several end-use industries.

Key Segments

Bag Size:

  • Very Small Bags (< 150 ml)
  • Small Bags (151 – 500 ml)
  • Medium Sized Bags (501 – 1000 ml)
  • Large Bags (1001- 3000 ml)
  • Very Large Bags (>3000 ml)

Application:

  • Storage
  • Mixing
  • Processing
  • Gas exchanges
  • Heat Transfer
  • Turbidity
  • Flow Rate Monitoring
  • Pressure
  • Viscosity

Host Cell:

  • Mesenchymal Cells
  • Plant Cells
  • Insect Cells
  • Bacteria Cells
  • Yeast Cells
  • Chinese Hamster Ovary
  • Baby Hamster Kidney

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12670

Bag Design:

  • 2D
  • 3D

End User:

  • Life Science R&D
  • Biopharmaceutical Manufacturers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • Oceania
  • East Asia
  • Middle East and Africa

Seasonal Affective Disorder Therapeutics Market Key Players – Allergan Plc, Eli Lily Company, GlaxoSmithKline Plc, Pfizer Inc., Novartis AG, Janssen Pharmaceuticals, Inc.

The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major shareholder in the market. Towards the end of 2019, more than 3.4 million devices are likely to be sold globally, in seasonal affective disorder therapeutics market.

[216 Pages Report] It has been noted that physicians across the globe are increasingly recommending Bright Light Therapy (BLT) as a prophylactic measure for Depression and Seasonal Affective Disorder Therapeutics. BLT provides a robust, rapid and completely anti-depressant effect. The light therapy onset should be typically within four days of Seasonal Affective Disorder. Monitoring should be done on a phase resetting basis on timed effects of introduction of bright light.

Popular drugs preferred in seasonal affective disorder therapeutics include selective serotonin reuptake inhibitors (SSRIs), according to the report. While generics and branded drugs are widely available in seasonal affective disorder therapeutics market, Buproban and Citalopram continue to register relatively higher sales. FMI attributes this dominance to high availability of generic versions of the aforementioned drugs.

To remain ‘ahead’ of your competitors, request for a sample

Bright light therapy that has been the most preferred line of treatment in seasonal affective disorder therapeutics continues to receive strong support from physicians and patients owing to positive end results. While more than half the sales of devices used in seasonal affective disorder therapeutics is accounted by light boxes, sales of desk lamps are also thriving at a brisk rate.

A highly recommended prophylactic measure involved in seasonal affective disorder therapeutics, light therapy is characterized by its rapid, reliable, and highly anti-depressant action. Extensive adoption of bright light therapy by the patients afflicted by a sub-syndromal disease and self-reporting patient population prompts at bolstered revenue visibility prospected for seasonal affective disorder treatment therapeutics in coming years.

key players

  • Allergan plc.,
  • Eli Lily Company,
  • GlaxoSmithKline plc,
  • Pfizer Inc.,
  • Teva Pharmaceuticals Inc.,
  • Bausch Health Companies Inc.,
  • F. Hoffmann-La Roche AG, Mylan N.V.,
  • Sanofi AG, Novartis AG,
  • Janssen Pharmaceuticals, Inc.,
  • The Sunbox Company,
  • Verilux, Inc.,
  • Carex Health,
  • Northern Light Technologies,
  • Beurer GmbH and Koninklijke Philips N.V.

seasonal affective disorder therapeutics market

Get a Customized Scope to Match Your Need Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-8821

Demand for Combination Therapy for SAD Picking Up

The report opines that light therapy is the first line of treatment that seasonal affective disorder therapeutics providers opt for. However, a possible ineffective outcome for certain patients of SAD related psychiatric illnesses and depression creates scope of combination therapies. Some of the recently reported clinical trials emphasize potential efficacy of combination of light therapy, psychotherapy, talk therapy, and antidepressants in seasonal affective disorder therapeutics.

Inaccessibility at workplaces or during traveling has been a shortfall of light box therapy over the years. To help patients suffering from SAD explore non-conventional alternatives to seasonal affective disorder therapeutics, Austria-based med-tech startup, Active Wearables, recently launched a wearable device – Pocket Sky – providing light therapy, practically anywhere. The wearable has a wireless charging feature and the battery life is claimed to last for a couple of weeks. The Pocket Sky will potentially serve as a portable and lightweight light therapy solution to patients of seasonal affective disorder. Such innovations will continue to innovate the seasonal affective disorder therapeutics market landscape.

Inadequate availability of research data and ineffective documentation, especially related to use of bright light and blue light in light therapy, is posing a long-term challenge to rapid revenue growth of seasonal affective disorder therapeutics market. Moreover, proven adversities associated with excessive use of antidepressants also remain a concern among physicians and patients alike, limiting healthy growth prospects of seasonal affective disorder therapeutics market.

The report tracks performance of global seasonal affective therapeutics market over 2018-2028. In-depth strategic profiles of some of the leading players have been covered in the report, including Allergan plc, Eli Lily Company, GlaxoSmithKline plc, Pfizer Inc., Teva Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Sanofi AG, Novartis AG, Janssen Pharmaceuticals, Inc., and Koninklijke Philips N.V. among others.

For more insights on global seasonal affective disorder therapeutics market through 2028, write in to press@futuremarketinsights.com

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8821

Key Segment

based on treatment type

  • light boxes
  • dawn stimulators
  • desk lamps
  • sun visors

based on disorder type

  • SSRIs
  • SNRIs
  • NDRIs
  • TCAs
  • MOAIs

based on Distribution channel

  • institutional sales
  • retail sales

based on regions

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania and MEA

Europe Viscosupplementation Market Is Expected To Expand At A CAGR Of 5.1% Over The Forecast Period

Future Market Insights (FMI) delivers key insights on the Europe viscosupplementation market in its upcoming report titled, “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026”. In terms of revenue, the Europe viscosupplementation market is projected to register a healthy CAGR of 5.1% during 2016-2026.

FMI’s report has segmented the market on the basis of product type, end user and region.

Based on product type, the market has been segmented into one injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.

Single injection viscosupplementation product type segment is expected to emerge as the most popular segment over the forecast period, driven by better patient compliance as the treatment reduces the need for multiple hospital visits. The segment is expected to register the highest CAGR of 6.7% during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample

Five injection viscosupplementation product type segment is expected to witness a decline in market share in terms of revenue from 29.0% in 2015 to 23.3% in 2026. This decline is attributed to more incidence of side effects and repeated patient visit requirements associated with five injection viscosupplementation. Reimbursement cutbacks and high injection costs are other factors that can curtail demand for five injection viscosupplementation.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals end-use segment is expected to witness significant demand for viscosupplementation, registering a CAGR of 4.3% over the forecast period. Better reimbursement options and increasing patient preference for single injection cycle for osteoarthritis treatment is expected to drive demand for one injection viscosupplementation in the orthopaedic clinics segment over the forecast period.

 

europe-viscosupplementation-market

Europe Viscosupplementation Market Trends

Key trends in the viscosupplementation market are the use of single injection cycle for osteoarthritis treatment and introduction of new combination products in the market. For example, the product pipeline of major players in the viscosupplementation market involves combining corticosteroid injections, which help in relieving pain associated with osteoarthritis, with long-lasting effects of hyaluronic acid, which lasts for nearly six months. Further, regional competition within EU countries, especially in five injection cycle, is leading to entry of new market players. Europe is a mature market in terms of generic products and it is therefore relatively easier to obtain CE mark in Europe than it is to obtain the U.S. FDA approval.

Western Europe has been estimated to dominate the Europe viscosupplementation market in 2015, attributed to factors such as the presence of key regional players, strong distribution network and better healthcare infrastructure in the region.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-eu-1383

Key Players in Europe Viscosupplementation Market

  • Anika Therapeutics Inc.
  • Sanofi S.A.
  • Zimmer Biomet Holdings
  • Meda AB
  • Ferring B.V
  • Fidia Pharmaceutici S.p.A
  • Bioventus LLC.

We have discussed individual strategies followed by these companies in terms of enhancing product designs, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways that could help players already present in the market and new players planning to enter the market in the long run.

Market Dynamics

Growth of the Europe viscosupplementation market is mainly driven by rising obesity rates and growing patient awareness about effective treatment therapies for knee osteoarthritis, coupled with macroeconomic factors such as high unmet patient needs and strengthening of distribution network by key players in the viscosupplementation market.  Other prominent growth drivers include rapidly growing medical technology industry and cost-effectiveness of the treatment. However, economic issues in some Eastern European countries and reimbursement cutbacks are expected to hamper overall growth of the viscosupplementation market in Europe over the forecast period.

Viscosupplementation devices are classified under Class III category in Europe and are considered high-risk devices. They require premarket approval from notified bodies, including private organisations recognised by the European Free Trade Association (EFTA).

Key Segments

  • Product Type
    • Single Injection Viscosupplementation
    • Three Injection Viscosupplementation
    • Five Injection Viscosupplementation
  • End User
    • Hospitals
    • Ambulatory Surgical Centres
    • Orthopaedic Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-eu-1383

 Key Regions/Countries

  • Western Europe
    • U.K.
    • France
    • Germany
    • Spain
    • Italy
    • Nordics
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Rest of Eastern Europe

Molecular Imaging Market Will Expand At An Impressive CAGR Of Around 11.3% From 2021 To 2031

Molecular imaging is an emerging diagnostic technology that allows visualization, differentiation, and quantify various biological processes occurring inside a living organism at the molecular and cellular level. The global molecular imaging market is estimated to be valued approximately at US$ 4 Bn in 2021, finds Future Market Insights (FMI) in a study.

Clinical molecular imaging is trending towards hybrid modalities such as PET-CT, SPECT, or PET-MR that provide high-resolution anatomical imaging. PET-CT is anticipated to gain maximum revenue share over the forecast period, and the segment is projected to expand at a CAGR of 16.3% during the forecast period.

Molecular imaging targets molecular pathways and mechanisms associated with a particular disease present inside a living body. It enables to study of the molecular abnormalities taking place inside the body to carry out early detection of disease and to optimize medications aiming for disease-related molecular targets. Nuclear medicine plays a vital role in conducting a molecular imaging process and can be broadly used for the treatment of distinct cancer and related diseases.

Molecular imaging has evolved as a promising tool for early detection of cancers and cardiac diseases, providing a more complete picture of the tumor genome, as well as monitoring tumor emergence during disease. Molecular imaging provides the ability to accurately evaluate biological responses to the treatment of individual patients over time, opening the door to personalized medical techniques directed by molecular imaging reporters.

To remain ‘ahead’ of your competitors, request for a sample

Key Takeaways from Molecular Imaging Market Study

  • Molecular imaging market will register accelerating demand, enabling a y-o-y growth of nearly 11% in 2021
  • Backed by presence of a state-of-the-art healthcare infrastructure, the U.S. accounts for nearly 65% sales in North America
  • Driven by rising cases of cancer, the  U.K. market will exhibit above 14% y-o-y growth in 2021
  • Government initiatives aimed at offering advanced medical care will enable growth in Germany and France
  • The market in China is expected to surge at a CAGR of over 10% from 2021 to 2031

 “Increasing research & development activities in cancer-specific drug discovery and other chronic diseases are expected to boost demand for molecular imaging. Besides this, as a result of increasing incidence of cancer the demand for highly sensitive and precise diagnostic for better treatment solutions is increasing,” says a Future Market Insights analyst.

molecular imaging market region wise plc position and notable trends, 2021

Molecular Imaging Needs Rising In Response to Increasing Cancer Cases

According to the World Health Organization (WHO) in 2020, breast cancer emerged as the most common type of cancer, affecting 2.2 million people around the world.  Lung cancer has been the leading cause of death with over 1.7 Mn of total deaths in 2020. North America has the highest incidence rate of cancer followed by East Asia. This rise in the cancer population is leading to a rise in the demand for diagnostic imaging, thereby catalyzing the demand for molecular imaging.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-724

Who is Winning?

Key players in the molecular imaging market are keenly focusing on carrying out strategic activities such as acquisitions, collaborations, and mergers, product launch, global expansion to create a strong position in the market is leading to vigorous developments which are helping the market to grow at a considerable rate.

For instance, in 2019, Bruker Corporation launched a benchtop magnetic resonance spectrometer with a high-field 9.4 Tesla small animal MRI system with integrated in-line PET. Thus strengthening its product portfolio.

Strategies adopted by key players are often intended at global expansion. They largely  focus on product launches and mergers & acquisitions. There have been a few strategic partnerships among leading players to enhance the product line and better facilities for end-user.

In September 2020, Bruker Corporation announced the acquisition of Canopy Biosciences, LLC. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques.

Some of the key players are Key market players covered by Future Market Insights in the report are :

  • Hermes Medical Solutions
  • Bruker Corporation
  • GE Company
  • Fujifilm Holdings Corp.
  • Koninklijke Philips N.V.
  • Siemens AG
  • Toshiba Medical System Corp.
  • Mirada Medical Limited
  • Carestream Health, Inc.
  • Esaote SpA,
  • Positron Corporation,
  • Medisco Ltd.
  • Hitachi Medical Corp.
  • MIM Software Inc.

Molecular Imaging Market by Category 

Modality

  • Positron Emission Tomography (PET)
  • Positron Emission Tomography- Computed Tomography (PET-CT)
  • Positron Emission Tomography- Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography (SPECT)
  • Software
    • On Premises Solutions
    • Cloud Based Solutions
  • Magnetic Resonance
  • Molecular Ultrasound Imaging

Application

  • Cardiology
  • Oncology
  • Gastrointestinal Disorders
  • Neurology Disorders
  • Others

 End User

  • Hospitals
    • 500+ Beds
    • 200-499 Beds
    • Less than 200 Beds
  • Ambulatory Surgical Centres
  • Diagnostic Centres

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-724

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Diabetic Macular Edema Market Key Players – Novartis AG, Bayer AG, Allergan Plc., F. Hoffman-La Roche Ltd., Alimera Sciences Inc.

The global diabetic macular edema (DME) market is projected to register a sluggish expansion at 1.1% CAGR through 2027, according to a report by Future Market Insights (FMI). The report estimates the market to reach US$ 3710.2 Mn in 2017; by 2027 this number is expected to surpass US$ 4,000 Mn.

An Uptake of Intravitreal Implants by Patients to Drive Growth of the Market in North America

North America will remain dominant in the global diabetic macular edema market. An uptake of intravitreal implants by new as well as existing patients, who do not show any improvement post-treatment with intravitreal injections, is expected to sustain growth of the market in this region.

Although control of diabetes is a health priority in developed North American countries, such as the U.S., less attention is given to DME management, with diabetes-related caregivers tending to focus on treatment of diabetic complications. A major reason behind this is lack of effective treatment for DME in North America. In addition, an error exists between industry sponsored and independently run clinical trials. Most of the independent clinical trials for DME treatment lack long-term results pertaining to safety and efficacy of new combination therapies for DME. These factors are likely to inhibit growth of the market in North America.

To remain ‘ahead’ of your competitors, request for a sample 

Diabetic Macular Edema Market in Western Europe to Register the Highest CAGR through 2027

The diabetic macular edema market in Western Europe is expected to register a comparatively higher CAGR than other region segments through 2027. Pharmaceutical companies in this region are making substantial investments in research and development, new technologies, and infrastructure in order to capture a market share in the surging burden of eye diseases. This is expected to retain growth of the market in Western Europe.

However, patients in Western Europe resist the intake of intravitreal injections of anti-VEGF drugs, which leads to an instant increase in intraocular pressure causing severe pain in the head or eyes. This a major factor impeding growth of the diabetic macular edema market in Western Europe.

Anti-VEGF will Remain Preferred Product in the Global Diabetic Macular Edema Market

Anti-VEGF will remain preferred product in the market, with sales estimated to expand at 1% CAGR through 2027. Eylea will continue to be the most lucrative anti-VEGF drug in the market. However, demand for corticosteroids will remain comparatively lower than anti-VEGF during the forecast period.

By product form, intravitreal injections will continue to be sought-after in the market, with sales poised to surpass US$ 4,000 Mn by 2027-end. Sales of intravitreal implants will register a comparatively higher CAGR than intravitreal injections through 2027.

Hospital pharmacy is estimated to remain the largest distribution channel in the market, as majority of countries across the globe dispense intravitreal injections and implants to outpatients by hospital pharmacies. Retail pharmacy, which mainly provides aliquots of off-label indications such as Avastin prescription, will register a comparatively low CAGR than hospital pharmacy in the market through 2027.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2697

Key market players identified in FMI’s report include:

  • Novartis AG,
  • Bayer AG,
  • Allergan Plc., F.
  • Hoffman-La Roche Ltd.,
  • Alimera Sciences Inc.,
  • Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Inc.)

Key Segment

By Therapy Type

  • Anti-VEGF
    • Ranibizumab (Lucentis)
    • Afilbercept (Eylea)
  • Corticosteroids
    • Fluocinolone Acetonide (Iluvien)
    • Dexamethasone (Ozurdex)
  • Other Off-label Drugs (Triamcinolone Acetonide, Bevacizumab and Pegaptanib)

By Product Form

  • Intravitreal Injections
  • Intravitreal Implants

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2697

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Medical Pendant Market Insights, Deep Analysis of Key Vendor in the Industry 2021- 2026

The medical pendant systems provide appropriate positioning of medical equipment, terminal units, medical gas, specialty and electrical services. Medical pendant systems are mounted on the ceiling with the robust carcass system consisting of stainless steel flanges and supporting rods. Medical pendant is the compact system with various configurations to fulfill exact requirements of hospital. Medical pendants have various number of arms which can be help to accommodate all electrical services, medical gas, data communication services and facilitating equipment management. Incoming electrical and gas services from ceiling to minimize the cable clutter provide a safer and cleaner place for the movement and activity of medical professional teams. The movable arm of medical pendant system allows it to be located at exactly where it is most suitable for the operating team and these arms cover the requirement of any operation theatre. Medical pendants make medical tasks and procedures easier, while ensuring safety while placing monitoring equipment. Medical pendants are designed to maximize space in the operation theatre for operations and critical care areas to improve accessibility around the patient bed thereby enabling healthcare staff to deliver effective patient care.

Medical Pendant Market: Drivers and Restraints

The primary factor for the growth of global medical pendant market is growing awareness in the healthcare professionals andrequirement of safe and low risk work space for medical staff. Medical pendant systems are highly useful in operation theatres or in intensive care unit. The growth of medical pendant market is primarily attributed to accurate and effective results in various application areas such as surgeries and endoscopy. Major factor which limits the growth of the global medical pendant market is high cost of medical pendant system setup and unavailability of skilled nursing staff.

To remain ‘ahead’ of your competitors, request for a sample

Medical Pendant Market: Overview

Medical pendant systems are designed to remove standing devices from the operation floor around the patient bed. The unique design of medical pendant systems enables mounting of a number of medical devices in a compact space. The maximum range of movement enables quick, easy positioning of service and provides safety control while minimizing the infection risk. Medical pendant systems decrease the visual impact in the patient environment, increasing the capacity of equipment load and improving equipment access. Medical pendant systems allow various devices to be connected with it such as electrical supply, lighting, communication equipment, gas and liquid supply and rail system for installations of equipment. Medical pendant systems design enable different combinations and resources that fulfill the special needs and expectations of operating rooms in hospitals. Fixed Retractable Pendants and Double Multi Arm Movable Pendant product type segments are expected to register highest CAGRs in terms of value owing to faster adoption among the medical communities worldwide.

Medical Pendant Market: Region-wise Outlook

The global medical pendantsystem market is expected to register a healthy CAGR for the forecast period. Depending on geographic region, global medical pendant systemmarket is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America held largest share in the global market of medical pendant systemfollowed by Europe, Japan and Asia Pacific owing to the need for increasing the standard of healthcare infrastructure coupled with substantial investments. The developing nations in APAC and MEA hold huge potential for growth in the global medical pendant systemmarket, due to the convenience it offers in hospitals and ambulatory surgical centers.

Medical Pendant Market: Key Players

Some of the key participating global players in medical pendant systemsmarket are ELEKTRA HELLAS, Starkstrom, Ondal, Hipac, Beacon Medaes, Unicorn Medicals, Medilon, Uttam, Medimax, Brandon Medical.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1243

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
  • Eastern Europe (Poland, Russia, Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Medical Pendant Market: Segmentation

Global medical pendantmarket is classified on the basis of product type, application and geography

Based on product type, the global medical pendant market is segmented into the following:

  • Fixed Pendants
  • Fixed Retractable Pendants
  • Single Arm Movable Pendant
  • Double Multi Arm Movable Pendant

Based on application, the global medical pendant market is segmented into the following:

  • Surgery
  • Endoscopy
  • Anaesthesia
  • Intensive care Units

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1243

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint